Japanese Trying Out DNA Testing Due To Rapidly Aging Population


Daily Caller News Foundation logo
Font Size:

DNA testing that helps identify risks for certain medical conditions is growing in popularity in Japan due to its rapidly aging population.

Genetic testing companies Genesis HealthCare and Genequest Inc. are helping people anticipate potential health risks that are inherited through family bloodlines, according to Bloomberg. These two genetic testing companies are trying to accommodate the aging population in Japan with mouth swab tests that research the customer’s risks for strokes, diabetes, alcohol intolerance and allergies. The genetic tests run from about $44 to $266 to take. The genetic testing market is expected to reach $58 million by 2022, Fuji Chimera Research Institute reported. (RELATED: Cherry Blossoms Make Japan Most Popular Easter Tourist Destination)

Japanese food companies are also trying to accommodate the growing interest in genetic testing. Nestle Japan Co. joined forces with Genesis to create an app that provides nutrition guidelines for consumers based on their genetic tests results.

Health drink and supplement company Euglena Co. bought Genequest in 2017, and the two companies now provide a test to look for alcohol intolerance in customers. (RELATED: More Than A Quarter Of Japan Is Over The Age Of 65)

“I see a lot of potential in the business,” Shoko Takahashi, the founder of Genequest Inc. said, according to Bloomberg. (RELATED: This Island Has More Dolls Than People Living In It)

One-third of Japan’s rapidly aging population is expected to be 65 or older by 2035, according to the Annual Report on the Aging Society: 2016.

Follow Gabrielle on Twitter
Send tips to

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact